Pharma Capital
EPIC: OXP
Market: AIM
52-week High/Low: 7.89p / 1.50p
Sector: Pharma & Biotech
Market Cap: 34.36M
Phone: +44 (0)207 554 5875
Address: 2 Royal College Street, Camden, London NW1 0NH.
Website: www.oxfordpharmascience.com

Oxford Pharmascience Group Plc uses a range of proprietary technology platforms to re-develop existing medicines to make them better, safer or easier to take. The Company does not manufacture or sell its own pharmaceutical products direct to consumers but instead seeks to license its technologies and dossiers to a network of partners, mainly leading pharmaceutical companies with Rx (prescription) and OTC (Over the Counter) branded portfolios. 

Oxford Pharmascience Group Plc focuses on existing medicines that are proven to be safe and effective but nevertheless still have associated issues and side effects often affecting compliance. By working with such medicines the Company is able to develop new innovative products for a fraction of the cost, in much quicker timescales and without the high risk of failure associated with developing new drugs.

Oxford Pharmascience is traded in the ISDX Exchange HERE

Oxford Pharmascience

www.oxfordpharmascience.com

Interactive graph

col 3
col 4
col 5
col 6

Oxford Pharmascience Timeline

View All

Market Reports Including OXP

VIEW ALL

Executive video interviews

VIEW ALL VIDEOS

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.